Strategic M&A Ottobock’s recent acquisition of Fesia Technology signals a strategic expansion into functional electrical stimulation products within neuro-orthotics, presenting a sales opportunity to align with their enhanced portfolio and offer compatible components, services, or integrative solutions.

Divestment Signals The sale of the wheelchair business to a competitor indicates a potential realignment of product focus and channel strategy. Sales teams can target Ottobock for high-value partnerships, licensing opportunities, or replacement solutions in core mobility segments affected by the divestment.

Digitalisation Drive Ottobock emphasizes digitalisation of the industry; there is an opportunity to provide software-enabled fitting, remote patient monitoring, data analytics, and digital workflow solutions that streamline patient care clinics and enhance prosthetics/neuro-orthotics fitting precision.

Global Footprint With 45 countries and a broad patient-care network of around 400 clinics, Ottobock is a robust distribution and service platform. There is potential to offer scalable training, maintenance contracts, and localized purchasing programs to support their international operations.

R&D and IP Leadership A strong R&D focus, large patent portfolio, and recent innovations like 3D-printed silicone liners indicate opportunities to propose advanced materials, manufacturing collaboration, or joint development projects that complement Ottobock’s product roadmap and speed to market.